Combination of WEE1 Inhibitor and Vitamin K2 Enhances Therapeutic Efficacy in Chronic Myeloid LeukemiaOA
Combination of WEE1 Inhibitor and Vitamin K2 Enhances Therapeutic Efficacy in Chronic Myeloid Leukemia
Seiichi Okabe;Yuya Arai;Akihiko Gotoh;Daigo Akahane
Department of Hematology,Tokyo Medical University,Tokyo,JapanDepartment of Hematology,Tokyo Medical University,Tokyo,JapanDepartment of Hematology,Tokyo Medical University,Tokyo,JapanDepartment of Hematology,Tokyo Medical University,Tokyo,Japan
chronic myeloid leukemiavitamin K2WEE1 inhibitor
chronic myeloid leukemiavitamin K2WEE1 inhibitor
《肿瘤学创新（英文）》 2025 (5)
54-64,11
评论